1Libby P. What have we learned about the biology of atherosclerosis? The role of inflammation. Am J Cardiol, 2001,88:3J-6J.
2Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983, 51:606.
3Takanobu Takezako, Keijiro Saku, Bo zhang, et al. Insulin resistance and angiographical characteristics of coronary atherosclerosis Jpn Circ J, 1999, 63:666-673.
4Crndy S C. Primary prevention of coronary heart disease. Integrating risk assessment with intervention. Circulation, 1999,100:988-998.
5Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med, 1999,340:115-126.
6Hillis G S, Dalsey W C, Terregino C A, et al. Altered CD18 leukocyte integrin expression and adhesive function in patients with acute coronary syntrome. Heart, 2001, 85:702-704.
7Shah P K. Mechanisms of plaque nulnerability and rupture. J Am Coll Cardiol, 2003,41:S15-22.
8Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, et al. Multiple complex stenoses,high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis, 2004, 175:151-157.
9Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias,inflammatory, mechanisms and persistence of atrial fibrillation. Circulation, 2001, 104 (24): 2 886-891
10Bonora E, Targher G, Alberiche M, Bonadonna RC,Saggiani F,Zenere MB. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 2000, 23 (1): 57-63
